Pasithea Therapeutics Corp.

Q2 2026 13F Holders

Symbol
KTTA
CUSIP
70261F202
Type
Equity
Class
COM NEW
Num filings
25
Total reported value, excl. options
$8.66 M
Manager Report Date Value ($000) Shares Option Type